Is capecitabine a cost-effective adjuvant treatment of stage III colon cancer in Ontario?

被引：0
|
作者：
Orchard, M. C. [1 ]
Hoch, J. S. [1 ]
Alibhai, S. M. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15024
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Is capecitabine a cost-effective adjuvant treatment of stage III colon cancer in Ontario?
    Orchard, M. C.
    Hoch, J.
    Alibhai, S. M. H.
    VALUE IN HEALTH, 2008, 11 (03) : A60 - A60
  • [2] Capecitabine as adjuvant treatment for stage III colon cancer
    Twelves, C
    Wong, A
    Nowacki, MP
    Abt, M
    Burris, H
    Carrato, A
    Cassidy, J
    Cervantes, A
    Fagerberg, J
    Georgoulias, V
    Husseini, F
    Jodrell, D
    Koralewski, P
    Kröning, H
    Maroun, J
    Marschner, N
    McKendrick, J
    Pawlicki, M
    Rosso, R
    Schüller, J
    Seitz, JF
    Stabuc, B
    Tujakowski, J
    Van Hazel, G
    Zaluski, J
    Scheithauer, W
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2696 - 2704
  • [3] Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
    S Eggington
    P Tappenden
    A Pandor
    S Paisley
    M Saunders
    M Seymour
    P Sutcliffe
    J Chilcott
    British Journal of Cancer, 2006, 95 : 1195 - 1201
  • [4] Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
    Eggington, S.
    Tappenden, P.
    Pandor, A.
    Paisley, S.
    Saunders, M.
    Seymour, M.
    Sutcliffe, P.
    Chilcott, J.
    BRITISH JOURNAL OF CANCER, 2006, 95 (09) : 1195 - 1201
  • [5] Pharmacoeconomic analysis of capecitabine in adjuvant treatment of stage III colon cancer in Taiwan
    Hsu, T. C.
    Chen, H. H.
    Chen, L. T.
    Changchien, C. R.
    Liu, M. C.
    Wang, H. M.
    Yang, L.
    VALUE IN HEALTH, 2007, 10 (03) : A11 - A12
  • [6] Adjuvant treatment of stage III colon cancer
    Koehne, C.-H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 12 - 13
  • [7] Adjuvant capecitabine treatment for stage III colon cancer in Japanese patients (KSCC0803)
    Kitazono, M.
    Emi, Y.
    Kakeji, Y.
    Sakaguchi, Y.
    Samura, H.
    Ogata, Y.
    Natsugoe, S.
    Shirouzu, K.
    Tokunaga, S.
    Maehara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer
    Lamberti, C
    Sauerbruch, T
    Glasmacher, A
    CANCER TREATMENT REVIEWS, 2005, 31 (08) : 648 - 652
  • [9] Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting
    Douillard, J. Y.
    Tilleul, P.
    Ychou, M.
    Dufour, P.
    Perrocheau, G.
    Seitz, J. F.
    Maes, P.
    Lafuma, A.
    Husseini, F.
    ONCOLOGY, 2007, 72 (3-4) : 248 - 254
  • [10] Capecitabine based adjuvant therapy for stage III colon cancer - single institution experience
    Mitreski, N.
    Angelovska, N.
    Grozdanovska, B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S15 - S15
12345